Ecstasy Drug Trials Missed Suicidal Thoughts of Subjects

Participants in studies of the psychedelic, which is up for U.S. approval, told the WSJ they felt pressure to report positive benefits.

Leave a Reply

Your email address will not be published. Required fields are marked *